RCT to Examine the Effects of Scanning

March 4, 2013 updated by: University of Pennsylvania

An RCT to Examine the Effects of Scanning; a Major Step on the Path Towards Population Intervention

The purpose of the study is to implement a randomized control trial testing effects of information scanning on cancer prevention and screening behaviors in a population sample of 50-70 year olds. Participants will receive one of five versions of an e-newsletter once/month for 12 months and will be asked to complete baseline, mid-point, and end-of-project surveys.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

15824

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19104
        • University of Pennsylvania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • US adults, male or female, between 50 and 70 years of age.

Exclusion Criteria:

  • Potential subjects will be excluded if they are not between the ages of 50 and 70

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise
Participant received health newsletter with targeted articles about exercise behavior.
Behavioral: Health Newsletter
Participants received a health newsletter with articles about general health articles, as well as targeted health articles (differs by condition).
Experimental: Fruit & Vegetable
Participant received health newsletter with targeted articles about fruit & vegetable consumption.
Behavioral: Health Newsletter
Participants received a health newsletter with articles about general health articles, as well as targeted health articles (differs by condition).
Experimental: Colorectal Cancer Screening
Participant received health newsletter with targeted articles about colorectal cancer screening.
Behavioral: Health Newsletter
Participants received a health newsletter with articles about general health articles, as well as targeted health articles (differs by condition).
Experimental: Mammography
Participant received health newsletter with targeted articles about mammography screening.
Behavioral: Health Newsletter
Participants received a health newsletter with articles about general health articles, as well as targeted health articles (differs by condition).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise Behavior
Time Frame: 12 months
The Godin Scale was used to assess weekly exercise frequency and intensity
12 months
Fruit & Vegetable Consumption
Time Frame: 12 months
Total daily servings of reported fruits and vegetables (maximum of 10) were calculated using a composite measure that summed separate responses for fruits and vegetables.
12 months
Mammography Screening Behavior
Time Frame: 12 months
We used responses to two questions to create a dichotomous measure of whether or not female respondents (all aged 50 to 70) received a mammogram in the past year.
12 months
Colorectal cancer screening
Time Frame: 12 months
A measure of up-to-date colorectal cancer screening status was assessed using individuals' self-reports of recency of colonoscopy (within 10 years), sigmoidoscopy (within five years), and/or fecal occult blood test (FOBT) within one year.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Pennsylvania

Collaborators

National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Robert Hornik, PhD, University of Pennsylvania

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2010

Primary Completion (Actual)

May 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

February 25, 2013

First Submitted That Met QC Criteria

March 4, 2013

First Posted (Estimate)

March 5, 2013

Study Record Updates

Last Update Posted (Estimate)

March 5, 2013

Last Update Submitted That Met QC Criteria

March 4, 2013

Last Verified

December 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 811285
  • 3P20CA095856-07S1 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Health Newsletter

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe